They found that clonal TMB was the strongest predictor of immunotherapy response, and they found that the expression of total TMB and CXCL9 also had good predictive value, However, subclone TMB and somatic copy change load did not gain significant significance in pan cancer analysis, and these markers were internal determinants of tumors. Here, CXCL9 is linked to cancer.